Today: 20 July 2026
UnitedHealth stock price today: UNH ticks up as Medicare Advantage rates and U.S. data loom
9 February 2026
1 min read

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rates and U.S. data loom

New York, February 9, 2026, 11:39 EST — Regular session

UnitedHealth Group Incorporated (UNH) inched up 0.3% to $277.44 by late morning Monday. Shares moved within a range of $273.88 to $278.36.

Even a tiny change like that matters, since UNH’s fortunes are still tightly linked to Medicare Advantage—those private senior and disability plans shaped by federal payment policies. The Centers for Medicare & Medicaid Services has floated its 2027 Advance Notice, flagging just a 0.09% bump in average payments. Comments are open through Feb. 25, and the agency is due to lock in the final rate by April 6.

Stocks in the U.S. got off to a mixed start this morning. Investors kept an eye on interest rate signals following last week’s tech slump. The Dow slipped roughly 0.3%. The S&P 500 was little changed, while the Nasdaq managed a slight uptick, according to Reuters.

UnitedHealth posted 2025 revenue of $447.6 billion on Jan. 27, a 12% increase, and projected 2026 revenue to top $439.0 billion with adjusted earnings expected to exceed $17.75 per share. CEO Stephen Hemsley, in prepared comments, said the company “confronted challenges directly” and wrapped up 2025 “as a much stronger company.” UnitedHealth Group

Investors didn’t like the news: shares dropped up to 19% on Jan. 27 after the company signaled its first revenue drop since 1989, according to Reuters. Hemsley talked up noticeable “momentum” inside the company, but UnitedHealthcare chief Tim Noel flagged “meaningful benefit reductions” coming. Morningstar’s Julie Utterback told investors looking for a fast turnaround they “may have to wait longer than hoped.” For 2026, UnitedHealth projected its medical care ratio—how much of premiums go toward medical costs—at roughly 88.8%, an important profit metric for the sector. Reuters

UnitedHealth isn’t alone when it comes to rising costs. Molina Healthcare on Feb. 6 slashed its 2026 profit outlook, blaming higher medical expenses, and announced it will walk away from Medicare Advantage prescription drug plans in 2027. CEO Joseph Zubretsky called 2026 a “trough year” for Medicaid margins. Reuters

UNH faces a tough setup right now: reimbursement remains squeezed, and care utilization just won’t cool off. Insurers could try to prop up margins by cutting back on benefits or pulling back from certain markets—though moves like that risk slowing down membership gains and drawing extra attention.

Scrutiny isn’t new. Back in January, a Senate committee report accused UnitedHealth of employing aggressive risk-adjustment coding tactics—essentially, a method that increases payments for plans serving sicker Medicare Advantage patients—to ramp up reimbursement. The company pushed back, saying it disagreed with the report’s take and insists its programs follow regulations.

No obvious company news to kick things off Monday, so traders will be eyeing the U.S. macro calendar. First up: the January Employment Situation lands at 8:30 a.m. ET on Feb. 11. Just two days later, January’s Consumer Price Index hits at 8:30 a.m. ET on Feb. 13, per Labor Department schedules.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • BlackRock's IBIT Drives Bitcoin ETF Rally as Rivals See Withdrawals
    July 20, 2026, 5:08 AM EDT. BlackRock's iShares Bitcoin Trust (NASDAQ:IBIT) led a rebound for Bitcoin ETFs by pulling in $496 million over the last two weeks, undoing eight weeks of outflows that had summed to more than $8 billion. Still, competing funds registered net outflows totalling $223.1 million, with Fidelity Wise Origin (BATS:FBTC) seeing $274.5 million in redemptions. Combined net inflows for U.S. spot Bitcoin ETFs reached $272.9 million. Bitcoin hovered near $64,000, slipping slightly in early session trading. Options market activity reflected bullish sentiment, with an uptick in call spread trades targeting the $70,000-$72,000 range. Analysts point to the need for sustained inflows across multiple weeks and broader ETF participation to verify a market recovery extending beyond IBIT's strong showing.
Merck stock is inches from a 52-week high — and an insider just sold shares
Previous Story

Merck stock is inches from a 52-week high — and an insider just sold shares

Dauch (DCH) stock rises in early trade as board changes and exec share award hit filings
Next Story

Dauch (DCH) stock rises in early trade as board changes and exec share award hit filings

Go toTop